Related Experiment Video

Updated: Jul 23, 2026

Isolation and Characterization of Neutrophils with Anti-Tumor Properties
10:15

Isolation and Characterization of Neutrophils with Anti-Tumor Properties

Published on: June 19, 2015

Suppressor of cytokine signaling 3 expression in anaplastic large cell lymphoma

J H Cho-Vega1, G Z Rassidakis, H M Amin

  • 1Department of Molecular Pathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA.

Leukemia
|September 24, 2004
PubMed

Insights

Suppressor of cytokine signaling 3 (SOCS3) is highly expressed in anaplastic large cell lymphoma (ALCL), potentially via the Janus kinase 3 (JAK3)-signal transducer and activator of transcription 3 (STAT3) pathway. SOCS3 upregulation in ALCL suggests a role in disease pathogenesis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Immunology

Background:

  • Anaplastic large cell lymphoma (ALCL) is a distinct subtype of non-Hodgkin lymphoma.
  • The Janus kinase (JAK)-signal transducer and activator of transcription (STAT) pathway is frequently dysregulated in lymphoid malignancies.
  • Suppressor of cytokine signaling 3 (SOCS3) is a key negative regulator of cytokine signaling.

Purpose of the Study:

  • To investigate the role of SOCS3 in the pathogenesis of anaplastic lymphoma kinase (ALK)+ ALCL.
  • To explore the relationship between SOCS3, ALK, and the JAK3-STAT3 pathway in ALCL.

Main Methods:

  • cDNA microarray analysis to assess SOCS3 expression.
  • Coimmunoprecipitation to determine physical binding between SOCS3 and JAK3.
  • JAK3 inhibition using WHI-P154.
  • Western blot analysis for SOCS3 and phosphorylated STAT3 (pSTAT3) expression.
  • Direct sequencing of the SOCS3 gene.
  • Immunohistochemistry to evaluate SOCS3 and pSTAT3 expression in ALCL tumors.

Main Results:

  • SOCS3 was highly expressed in ALK+ ALCL cell lines.
  • SOCS3 physically binds with JAK3 in vitro, and JAK3 inhibition downregulates SOCS3 expression.
  • SOCS3 and pSTAT3 were coexpressed in a majority of ALK+ and ALK- ALCL tumors.
  • No mutations or alternative splicing were found in the SOCS3 gene.
  • SOCS3 is overexpressed in ALCL, linked to JAK3-STAT3 activation and potentially ALK in ALK+ tumors.

Conclusions:

  • SOCS3 is overexpressed in ALCL and may play a role in ALK+ ALCL pathogenesis through the JAK3-STAT3 pathway.
  • The expression of SOCS3 in ALCL tumors suggests its involvement in the disease, potentially mediated by JAK3-STAT3 activation.
  • Alternative mechanisms for SOCS3 upregulation exist in ALCL tumors lacking STAT3 and ALK.

More Related Videos

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome07:23

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome

Published on: June 15, 2016

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries08:49

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Published on: January 22, 2019

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...